Stay updated on Rucaparib in Platinum-Sensitive Ovarian Cancer Clinical Trial

Sign up to get notified when there's something new on the Rucaparib in Platinum-Sensitive Ovarian Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Rucaparib in Platinum-Sensitive Ovarian Cancer Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The displayed site revision changed from v3.8.0 to v3.8.1, with the clinical trial record otherwise unchanged.
    Difference
    0.0%
    Check dated 2026-11-18T01:44:08.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    The page now presents the full ARIEL2 study record for rucaparib in patients with platinum-sensitive, relapsed ovarian, fallopian tube, or primary peritoneal cancer, including study details, eligibility criteria, outcomes, and participating locations.
    Difference
    89%
    Check dated 2026-11-10T23:00:30.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    The footer identifies the site revision as v3.8.0 instead of v3.7.2; the study record remains inaccessible behind a 403 error.
    Difference
    0.2%
    Check dated 2026-11-03T23:08:03.000Z thumbnail image
  4. Check
    33 days ago
    Change Detected
    Summary
    A sitewide banner announces an NIH terminology transition from “Artificial Intelligence” to “Super Intelligence.” The site revision advances from v3.7.1 to v3.7.2.
    Difference
    1%
    Check dated 2026-10-20T22:28:21.000Z thumbnail image
  5. Check
    47 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.0 to v3.7.1 while the page continues to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-06T22:28:23.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    The study page now shows a 403 Forbidden error instead of the ARIEL2 trial details, and the related study content has been removed, leaving only the error message.
    Difference
    18%
    Check dated 2026-09-22T23:19:56.000Z thumbnail image

Stay in the know with updates to Rucaparib in Platinum-Sensitive Ovarian Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Rucaparib in Platinum-Sensitive Ovarian Cancer Clinical Trial page.